CLDF Title
Home | Contact Us | Bookmark
Embassy of Education  
Slide Library Webcasts Abstract Library LiverQ Academy
Reuters Health Information: Second Los Angeles hospital identifies 'superbug' infections

Second Los Angeles hospital identifies 'superbug' infections

Last Updated: 2015-03-05

By Steve Gorman

LOS ANGELES (Reuters) - A second top Los Angeles hospital has reported an outbreak of drug-resistant superbug infections, and dozens more potential exposures, from procedures performed with a duodenoscope.

The notice from Cedars-Sinai Medical Center of four such infections and 67 more patients who were at risk coincided with a hospital in Hartford, Connecticut, reporting a similar outbreak involving at least five infections and more than 280 potential exposures.

The Cedars-Sinai cases, like the larger number of infections and potential exposures reported last month at the UCLA Ronald Reagan Medical Center in Los Angeles, involved carbapenem-resistant Enterobacteriaceae, or CRE.

The bacteria identified on Wednesday in the Hartford Hospital outbreak was a drug-resistant strain of E.coli.

But the procedure and instrument implicated at all three hospitals were the same - endoscopic retrograde cholangiopancreatography, or ERCP, performed with a duodenoscope.

The Food and Drug Administration, meanwhile, issued an updated safety alert for duodenoscopes, urging medical providers to inform patients of the risks, including possible transmission of infection, associated with the use of such instruments.

The alert also puts providers on notice to report any infections they suspect were caused by problems with the scopes to the manufacturer and the FDA.

The latest flurry of infections has raised new questions about whether manufacturers' recommendations for disinfecting duodenoscopes are sufficient to protect patients.

The complex design of the instrument may hinder proper cleaning, the FDA has warned.

A senior FDA official said this week that manufacturers' own tests of disinfection measures they recommend contained flaws that rendered those cleaning procedures unreliable.

Makers of the devices include Olympus Corp, Fujifilm Holdings Corp and Pentax.

Olympus was the maker of the single duodenoscope linked to all 71 patients of concern at Cedars-Sinai, from August 2014 to February 2015, and of two suspect scopes tied to 179 potential exposures dating back to October at UCLA.

Seven of UCLA patients were confirmed to have been infected, and two of them had died.

One of the four infected Cedars-Sinai patients died from "an underlying disease," not from the bacteria, as the infection had by then been cleared, the hospital said in its statement.

Hartford Hospital said it found five or six of its patients had contracted drug-resistant E.coli last year from two duodenoscopes used in 281 more procedures, leading doctors to conclude that those additional patients may have been exposed.

Both privately run Cedars-Sinai and UCLA, a public hospital, say they were offering potentially exposed patients free home-testing kits. The two facilities also said they have begun using enhanced disinfection procedures, above and beyond the manufacturer recommendations.

Duodenoscopes have been associated with episodic infections for more than a decade. But an increasing number of germs have developed a resistance to antibiotics, making them potentially more dangerous and difficult to treat.



Be the first to know about our latest upcoming programs and events!


Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2022 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.